COMPASS Pathways plc Income Statement
CMPS / Health Care|6 years of annual SEC 10-K data (FY2019-FY2024)
Line items include revenue, cost of goods sold, gross profit, operating expenses, interest, taxes, and net income with per-share data across 6 fiscal years. All figures from audited SEC 10-K filings.
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score -0.93 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
| Item | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|
| SG&A Expense | $59.2M | $49.4M | $45.4M | $39.2M | $28.0M | $8.6M |
| R&D Expense | $119.0M | $87.5M | $65.1M | $44.0M | $23.4M | $12.6M |
| Operating Income | -$178.2M | -$136.9M | -$110.4M | -$83.2M | -$51.4M | -$21.2M |
| Interest Expense | $4.5M | $2.2M | $0 | $0 | - | - |
| Income Tax | $1.6M | $780.0K | $408.0K | $199.0K | $32.0K | $15.0K |
| Net Income | -$155.1M | -$118.5M | -$91.5M | -$71.7M | -$60.3M | -$19.6M |
| EPS (Basic) | -$2.30 | -$2.32 | -$2.16 | -$1.79 | -$3.55 | -$2.62 |
| EPS (Diluted) | -$2.30 | -$2.32 | -$2.16 | -$1.79 | -$3.55 | -$2.62 |
| Shares Outstanding | 67.5M | 51.0M | 42.4M | 40.0M | 17.0M | 7.5M |